Amicus Therapeutics, Inc(NASDAQ:FOLD) 
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed dia...
Website: http://www.amicusrx.com
Founded: 2002
Full Time Employees: 584
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.89
H 7.89
L 7.39
C 7.50
V 3,184,954
10EMA 7.50
20EMA 7.50
60EMA 7.50
120EMA 7.50
250EMA 7.50